// App-Quantinova.ai

: Gendered Social Determinants of Health and Risk of Major Adverse Outcomes in Atrial Fibrillation An Analysis From the ESC-EHRA Eurobservational Research Programme in Atrial Fibrillation General Long-Term Registry

Researchers

Presenter

  • Jonathan Houle

Principal Investigators

  • Marco Proietti

  • Valeria Raparelli

  • Zahra Azizi

  • Clare Atzema

  • Colleen M Norris

  • Michal Abrahamowicz

  • Gregory Lip

  • Giuseppe Boriani

  • Louise Pilote

Medical Centers

  • McGill Univ., Montreal, Quebec, Canada

  • Cntr for Outcomes Rsch & Evaluation, Rsch Institute of the McGill Univ Health Cntr, Montreal, Canada

  • University of Alberta, Edmonton, AB, Canada

  • Department of Translational Medicine, University of Ferrara, Ferrara, Italy

  • Unit of Endocrinology, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy

  • Health Sciences Cntr, Sunnybrook Rsch Institute, Toronto, Canada

  • University of Milan, Milan, Italy

  • Dept of Medicine, Div of Internal Medicine, McGill Univ Health Cntr, Montreal, Canada

  • Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart & Chest Hospital, Liverpool, United Kingdom

  • Stanford University, Sunnyvale, CA

Locations

  • United States

  • Canada

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved